FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of organic chemistry and pharmaceuticals and is aimed at treating functional diseases of the gastrointestinal tract. Presented is a compound by the general structural formula I, wherein R1, R2 constitute H, Cl, Br, while at least one of R1 and R2 is Cl or Br. Described are a pharmaceutical composition containing the above compound, a medicinal product, and a finished dosage form for treating or preventing functional diseases of the gastrointestinal tract. Also presented is an application of the compound by the formula I and a pharmaceutical composition for treating or preventing functional diseases of the gastrointestinal tract, as well as for a pharmaceutical composition and a medicinal product.
EFFECT: effective treatment of functional diseases of the gastrointestinal tract.
58 cl, 5 tbl, 4 ex
Authors
Dates
2022-08-02—Published
2021-04-22—Filed